Clinical Evaluation |
---|
Expression of prostate specific membrane antigen |
Type of Imaging |
PET |
Grade of Recommendation |
A (strongly recommended) |
Level of Evidence |
well-designed NM recommendations |
Effective Dose |
20.0 µSv/MBq |
Bibliographic Reference |
Mottet, N., van den Bergh, R.C.N., Briers, E., Van den Broeck, T., Cumberbatch, M.G., De Santis, M., Fanti, S., Fossati, N., Gandaglia, G., Gillessen,...
read more
Mottet, N., van den Bergh, R.C.N., Briers, E., Van den Broeck, T., Cumberbatch, M.G., De Santis, M., Fanti, S., Fossati, N., Gandaglia, G., Gillessen, S., Grivas, N., Grummet, J., Henry, A.M., van der Kwast, T.H., Lam, T.B., Lardas, M., Liew, M., Mason, M.D., Moris, L., Oprea-Lager, D.E., van der Poel, H.G., Rouvière, O., Schoots, I.G., Tilki, D., Wiegel, T., Willemse, P.M., Cornford, P. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2021; https://doi.org/10.1016/j.eururo.2020.09.042
Hofman, M.S., Lawrentschuk, N., Francis, R.J., Tang, C., Vela, I., Thomas, P., Rutherford, N., Martin, J.M., Frydenberg, M., Shakher, R., Wong, L.M., Taubman, K., Ting Lee, S., Hsiao, E., Roach, P., Nottage, M., Kirkwood, I., Hayne, D., Link, E., Marusic, P., Matera, A., Herschtal, A., Iravani, A., Hicks, R.J., Williams, S., Murphy, D.G. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet. 2022; https://doi.org/10.1016/S0140-6736(20)30314-7. Cornford, P., van den Bergh, R.C.N., Briers, E., Van den Broeck, T., Cumberbatch, M.G., De Santis, M., Fanti, S., Fossati, N., Gandaglia, G., Gillessen, S., Grivas, N., Grummet, J., Henry, A.M., der Kwast, T.H.V., Lam, T.B., Lardas, M., Liew, M., Mason, M.D., Moris, L., Oprea-Lager, D.E., der Poel, H.G.V., Rouvière, O., Schoots, I.G., Tilki, D., Wiegel, T., Willemse, P.M., Mottet, N. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer. Eur Urol. 2021; https://doi.org/10.1016/j.eururo.2020.09.046 read less |
Guide to Nuclear Medicine |
Read the corresponding chapter |